Diisopropylethylamine → HCID 86643332, compound
Reaction equation
[Cl:1][C:2]1[C:6]([Cl:7])=[C:5]([CH3:8])[NH:4][C:3]=1[C:9]([NH:11][C@H:12]1[CH2:17][CH2:16][N:15]([C:18]2[S:19][C:20]([C:23](O)=[O:24])=[CH:21][N:22]=2)[CH2:14][C@H:13]1[O:26][CH3:27])=[O:10].CN([C:31]([O:35][N:36]1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=NC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.Cl.CON>CC(N(C)C)=O.CCOC(C)=O>[Cl:1][C:2]1[C:6]([Cl:7])=[C:5]([CH3:8])[NH:4][C:3]=1[C:9]([NH:11][C@H:12]1[CH2:17][CH2:16][N:15]([C:18]2[S:19][C:20]([C:23]([NH:36][O:35][CH3:31])=[O:24])=[CH:21][N:22]=2)[CH2:14][C@H:13]1[O:26][CH3:27])=[O:10]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
Cis(±)2-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2 -yl)carbonyl]amino}-3-methoxypiperidin-1-yl)-1,3-thiazole-5-carboxylic acid (Example 35; 100 mg) was dissolved in anhydrous DMA (2 ml). HATU (97 mg), HOAT (31 mg), DIEA (41 μl) were added and the mixture was stirred for 30 min. N-Methoxyamine hydrochloride (19.3 mg) was added followed by DIEA (41 μl), and the mixture was stirred at room temperature for 16 h. The reaction mixture was diluted with EtOAc, washed with H2O, 20% citric acid solution, H2O, sat. NaHCO3, H2O, brine and dried over Na2SO4. The organic phase was concentrated in vacuo to give the title compound as an off-white solid (82 mg). MS (ES)(MH+): 462, 460 for C17H21Cl2N5O4S; NMR: 1.64 (m, 2H), 1.85 (m, 1H), 2.05 (s, 3H), 2.83 (m, 1H), 3.33 (m, 5H), 3.73 (s, 3H), 4.07 (m, 1H), 4.38 (m, 2H), 7.24 (d, 1H), 7.74 (s, 1H), 11.39 (s, 1H), 12.05 (s, 1H).
Workup
- stirringthe mixture was stirred at room temperature for 16 h
- washwashed with H2O, 20% citric acid solution, H2O, sat. NaHCO3, H2O, brine
- dry with materialdried over Na2SO4
- concentrationThe organic phase was concentrated in vacuo
Sources & evidence
- ORD record
- ord-c39450f364ba4e2f8df44d24f0ce79a5
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08399489B2
Reaction notes
Loading…